Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Benatar

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
Molecular Neurodegeneration|June 14, 2017
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTDRustam Esanov, Gabriela Toro Cabrera, Nadja S Andrade, et al.
Neurology|November 21, 2020
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control TrialVera Bril, Michael Benatar, Henning Andersen, et al.
Neurology|April 18, 2018
Increased cerebral functional connectivity in ALS: A resting-state magnetoencephalography studyMalcolm Proudfoot, Giles L Colclough, Andrew Quinn, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 29, 2018
Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography systemJeremy M Shefner, Seward B Rutkove, James B Caress, et al.
JCI Insight|May 17, 2019
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosisIlya Gertsman, Joanne Wuu, Melissa McAlonis-Downes, et al.
Scientific Reports|June 9, 2021
FGF23, a novel muscle biomarker detected in the early stages of ALSYing Si, Mohamed Kazamel, Michael Benatar, et al.
Neurology. Clinical Practice|December 29, 2023
Blepharoclonus in ParkinsonismJason Margolesky, Matthew Feldman, Sarah Marmol, et al.
European Journal of Neurology|December 30, 2021
Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosisStephanie R Shepheard, Vassilios Karnaros, Beben Benyamin, et al.
Neurology|May 20, 2016
Presymptomatic ALS genetic counseling and testing: Experience and recommendationsMichael Benatar, Christine Stanislaw, Eliana Reyes, et al.
Human Brain Mapping|September 14, 2016
Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosisMalcolm Proudfoot, Gustavo Rohenkohl, Andrew Quinn, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
Molecular Neurodegeneration|June 14, 2017
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTDRustam Esanov, Gabriela Toro Cabrera, Nadja S Andrade, et al.
Neurology|November 21, 2020
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control TrialVera Bril, Michael Benatar, Henning Andersen, et al.
Neurology|April 18, 2018
Increased cerebral functional connectivity in ALS: A resting-state magnetoencephalography studyMalcolm Proudfoot, Giles L Colclough, Andrew Quinn, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 29, 2018
Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography systemJeremy M Shefner, Seward B Rutkove, James B Caress, et al.
JCI Insight|May 17, 2019
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosisIlya Gertsman, Joanne Wuu, Melissa McAlonis-Downes, et al.
Scientific Reports|June 9, 2021
FGF23, a novel muscle biomarker detected in the early stages of ALSYing Si, Mohamed Kazamel, Michael Benatar, et al.
Neurology. Clinical Practice|December 29, 2023
Blepharoclonus in ParkinsonismJason Margolesky, Matthew Feldman, Sarah Marmol, et al.
European Journal of Neurology|December 30, 2021
Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosisStephanie R Shepheard, Vassilios Karnaros, Beben Benyamin, et al.
Neurology|May 20, 2016
Presymptomatic ALS genetic counseling and testing: Experience and recommendationsMichael Benatar, Christine Stanislaw, Eliana Reyes, et al.
Human Brain Mapping|September 14, 2016
Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosisMalcolm Proudfoot, Gustavo Rohenkohl, Andrew Quinn, et al.
Pageof 25